Literature DB >> 4259384

Immune response to hepaitis virus type B in Down's syndrome and other mentally retarded patients.

F B Hollinger, R K Goyal, T Hersh, H C Powell, R J Schulman, J L Malnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4259384     DOI： 10.1093/oxfordjournals.aje.a121404

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  7 in total

1.  Safety and effectiveness of an acellular pertussis vaccine in subjects with Down's syndrome.

Authors:  S Li Volti; T Mattina; L Mauro; S Bianca; S Anfuso; A Ursino; F Mollica
Journal:  Childs Nerv Syst       Date:  1996-02       Impact factor: 1.475

2.  Hepatitis B and Down's syndrome.

Authors:  J Green
Journal:  BMJ       Date:  1988-11-19

3.  Hepatitis B surface antigen and its subtypes in an institution for the mentally retarded.

Authors:  E Perry; R K Chaudhary; T E Cleary; F R Roughley
Journal:  Can Med Assoc J       Date:  1975-01-11       Impact factor: 8.262

4.  Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.

Authors:  B C McMillan; R P Hanson; R Golubjatnikov; S K Sinha
Journal:  Public Health Rep       Date:  1979-06       Impact factor: 2.792

5.  Low prevalence of hepatitis B infections among residents of an institution for the mentally retarded in New Mexico.

Authors:  J M Mann; C J Babb; H F Hull; F D Ball; G W Brown; R S Steece
Journal:  West J Med       Date:  1984-09

6.  Hepatitis B infection in health care personnel of an institution for mentally handicapped children and adults.

Authors:  M L Tiku; K R Beutner; P Carmody; H A Sultz; B L Kaul; P L Ogra
Journal:  J Clin Microbiol       Date:  1976-05       Impact factor: 5.948

7.  The prevalence of serological markers, hepatitis B virus DNA and elevated serum amino transferase values in institutionalized mentally handicapped males and females: an epidemiological study of HBV infection in residents with Down's syndrome or other forms of mental deficiency.

Authors:  T J van Ditzhuijsen; F M Kleijnen; P J Rijntjes; A M van Loon; S H Yap
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.